Drug-Eluting Stents-Reference-Cited by-同舟云学术

Drug-Eluting Stents

Published:2003-06-24 Issue:24 Volume:107 Page:3008-3011
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

O’Neill William W.¹,Leon Martin B.¹

Affiliation:

1. From the Division of Cardiology Department of Internal Medicine, William Beaumont Hospital, Royal Oak, Mich (W.W.O.), and Cardiovascular Research Foundation, Division of Cardiovascular Diseases, Lenox Hill Hospital, New York, NY (M.B.L.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000079018.84618.0E

Reference15 articles.

1. Nonoperative Dilatation of Coronary-Artery Stenosis

2. Surgery or stent? The gap continues to narrow

3. Unrestricted availability of intracoronary stents is associated with decreased abrupt vascular closure rates and improved early clinical outcomes

4. A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

5. Moses JW. SIRIUS final results show 91% reduction in in-stent restenosis and 59% reduction in TVF. Transcatheter Therapeutics Meeting Washington DC 2002.

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes with Biolimus (A9)™ eluting stent, ‘BioMatrix’ in diabetic patients – interim results from multicenter post market surveillance registry in India;Indian Heart Journal;2013-09

2. Usefulness of Preprocedural Levels of Advanced Glycation End Products to Predict Restenosis in Patients With Controlled Diabetes Mellitus Undergoing Drug-Eluting Stent Implantation for Stable Angina Pectoris (From the Prospective ARMYDA-AGEs Study);The American Journal of Cardiology;2013-07

3. Computational modeling of effects of intravascular stent design on key mechanical and hemodynamic behavior;Computer-Aided Design;2012-08

4. Propensity score models in observational comparative effectiveness studies: cornerstone of design or statistical afterthought?;Journal of Comparative Effectiveness Research;2012-03

5. Unique Risks, Benefits, and Challenges of Developing Drug-Drug Combination Products in a Pharmaceutical Industrial Setting;Combination Products in Therapy;2012-01